Drug Screening

Drug Screening

Global Drug Screening Market to Reach $17.4 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Drug Screening estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$17.4 Billion by 2027, growing at aCAGR of 16.3% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 14% CAGR and reach US$9.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 20.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 15.8% CAGR

The Drug Screening market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3 Billion by the year 2027 trailing a CAGR of 15.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.3% and 14.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Select Competitors (Total 53 Featured) -

  • Alere, Inc.
  • Alfa Scientific Designs, Inc.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings (LabCorp)
  • Lifeloc Technologies, Inc.
  • Mpd, Inc.
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Premier Biotech, Inc.
  • Psychemedics Corporation
  • Quest Diagnostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Drug Screening – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Drug Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Breath by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Breath by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Oral Fluid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Oral Fluid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Hair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Hair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 25: World Drug Screening Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 27: USA Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 28: USA 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 29: USA Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 30: USA Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 31: USA 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 33: Canada Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 34: Canada 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 35: Canada Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 36: Canada Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 37: Canada 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
JAPAN
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 39: Japan Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 40: Japan 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 41: Japan Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 42: Japan Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 43: Japan 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
CHINA
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 44: China Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 45: China Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 46: China 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 47: China Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 48: China Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 49: China 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
EUROPE
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 51: Europe Historic Review for Drug Screening by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 52: Europe 15-Year Perspective for Drug Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 53: Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 54: Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 55: Europe 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 56: Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 57: Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 58: Europe 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
FRANCE
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 59: France Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 60: France Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 61: France 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 62: France Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 63: France Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 64: France 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
GERMANY
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 66: Germany Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 67: Germany 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 68: Germany Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 69: Germany Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 70: Germany 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 72: Italy Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 73: Italy 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 74: Italy Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 75: Italy Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 76: Italy 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
UNITED KINGDOM
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 78: UK Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 79: UK 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 80: UK Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 81: UK Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 82: UK 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 84: Rest of Europe Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 85: Rest of Europe 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 87: Rest of Europe Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 88: Rest of Europe 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Drug Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 90: Asia-Pacific Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 91: Asia-Pacific 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 94: Asia-Pacific 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 95: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Component - Products and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 96: Rest of World Historic Review for Drug Screening by Component - Products and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 97: Rest of World 15-Year Perspective for Drug Screening by Component - Percentage Breakdown of Value Sales for Products and Services for the Years 2012, 2021 & 2027
TABLE 98: Rest of World Recent Past, Current & Future Analysis for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 99: Rest of World Historic Review for Drug Screening by Sample Type - Urine, Breath, Oral Fluid, Hair and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 100: Rest of World 15-Year Perspective for Drug Screening by Sample Type - Percentage Breakdown of Value Sales for Urine, Breath, Oral Fluid, Hair and Other Sample Types for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings